Paired-pulse inhibition in the auditory cortex in parkinsons disease and its dependence on clinical characteristics of the patients

Stroke Research and Treatment

Volumn , Issue , 2011, Pages

  Lukhanina, Elena ^a   Berezetskaya, Natalia ^b   Karaban, Irina ^b  

^a BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^b INSTITUTE OF GERONTOLOGY   (Ukraine)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA; LEVODOPA; PRAMIPEXOLE; SELEGILINE;

ADULT; AGED; ARTICLE; ATTENTION; AUDITORY CORTEX; BRADYKINESIA; BRAIN FUNCTION; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; ONSET AGE; PAIRED PULSE INHIBITION; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; STIMULUS RESPONSE;

EID: 78650776149     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.4061/2011/342151     Document Type: Article

References (67)

1. Alexander G. E., Crutcher M. D., Functional architecture of basal ganglia circuits: neural substrates of parallel processing Trends in Neurosciences 1990 13 7 266 271
2. Lewis G. N., Byblow W. D., Altered sensorimotor integration in Parkinson's disease Brain 2002 125 9 2089 2099
3. Sailer A., Molnar G. F., Paradiso G., Gunraj C. A., Lang A. E., Chen R., Short and long latency afferent inhibition in Parkinson's disease Brain 2003 126 8 1883 1894
4. Chaudhuri K. R., Martinez-Martin P., Schapira A. H. V., Stocchi F., Sethi K., Odin P., Brown R. G., Koller W., Barone P., MacPhee G., Kelly L., Rabey M., MacMahon D., Thomas S., Ondo W., Rye D., Forbes A., Tluk S., Dhawan V., Bowron A., Williams A. J., Olanow C. W., International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study Movement Disorders 2006 21 7 916 923
5. DeLong M. R., Primate models of movement disorders of basal ganglia origin Trends in Neurosciences 1990 13 7 281 285
6. Ridding M. C., Inzelberg R., Rothwell J. C., Changes in excitability of motor cortical circuitry patients with Parkinson's disease Annals of Neurology 1995 37 2 181 188
7. Surmeier D. J., Kitai S. T., State-dependent regulation of neuronal excitability by dopamine Nihon Shinkei Seishin Yakurigaku Zasshi 1997 17 2 105 110
8. Pierantozzi M., Palmieri M. G., Marciani M. G., Bernardi G., Giacomini P., Stanzione P., Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study Experimental Brain Research 2001 141 1 52 62
9. Cantello R., Tarletti R., Civardi C., Transcranial magnetic stimulation and Parkinson's disease Brain Research Reviews 2002 38 3 309 327 (Pubitemid 34219109)
10. Bare M., Kaovsk P., Klajblov H., Rektor I., Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study European Journal of Neurology 2003 10 4 385 389
11. Morgante F., Espay A. J., Gunraj C., Lang A. E., Chen R., Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias Brain 2006 129 4 1059 1069
12. Chu J., Wagle-Shukla A., Gunraj C., Lang A. E., Chen R., Impaired presynaptic inhibition in the motor cortex in Parkinson disease Neurology 2009 72 9 842 849
13. Angleson J. K., Betz W. J., Monitoring secretion in real time: capacitance, amperometry and fluorescence compared Trends in Neurosciences 1997 20 7 281 287
14. Lvns C., Daniel H., Soubri P., Crpel F., Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells Journal of Physiology 1998 510 3 867 879
15. Szabo B., Wallmichrath I., Mathonia P., Pfreundtner C., Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata Neuroscience 2000 97 1 89 97
16. Neher E., Vesicle pools and Ca2+ microdomains: new tools for understanding their roles in neurotransmitter release Neuron 1998 20 3 389 399
17. Shen K.-Z., Johnson S. W., Presynaptic GABA(B) and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones Journal of Physiology 1997 505 1 153 163
18. Chu Z., Hablitz J. J., GABAB receptor-mediated heterosynaptic depression of excitatory synaptic transmission in rat frontal neocortex Brain Research 2003 959 1 39 49
19. Lei S., McBain C. J., GABAB receptor modulation of excitatory and inhibitory synaptic transmission onto rat CA3 hippocampal interneurons Journal of Physiology 2003 546 2 439 453
20. Stuart G. J., Determinants of spike timing-dependent synaptic plasticity Neuron 2001 32 6 966 968
21. Voronin L. L., Cherubini E., 'Deaf, mute and whispering' silent synapses: their role in synaptic plasticity Journal of Physiology 2004 557 1 3 12
22. Nakashima K., Nitta T., Takahashi K., Recovery functions of somatosensory evoked potentials in parkinsonian patients Journal of the Neurological Sciences 1992 108 1 24 31
23. Teo C., Rasco L., Al-Mefty K., Skinner R. D., Boop F. A., Garcia-Rill E., Decreased habituation of midlatency auditory evoked responses in Parkinson's disease Movement Disorders 1997 12 5 655 664
24. Perriol M.-P., Dujardin K., Derambure P., Marcq A., Bourriez J.-L., Laureau E., Pasquier F., Defebvre L., Deste A., Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease Journal of Neurology, Neurosurgery and Psychiatry 2005 76 1 106 108
25. Lukhanina E. P., Kapustina M. T., Berezetskaya N. M., Karaban I. N., Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease Clinical Neurophysiology 2009 120 10 1852 1858
26. Hoehn M. M., Yahr M. D., Parkinsonism: onset, progression and mortality Neurology 1967 17 5 427 442
27. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J., What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study Neurology 1992 42 6 1142 1146
28. Fahn S., Elton R., Members of the UPDRS Development Committee, Fahn S., Marsden C. D., Calne D. B., Goldstein M., Unified Parkinson's disease rating scale Recent developments in Parkinson's disease 1987 2 Florham Park, NJ, USA New Jersey Macmillan Health Care Information 153 163, 293304
29. Holloway R. G., Shoulson I., Fahn S., Pramipexole vs levodopa as initial treatment for Parkinson Disease: a 4-year randomized controlled trial Archives of Neurology 2004 61 7 1044 1053
30. Davis H., Mast T., Yoshie N., Zerlin S., The slow response of the human cortex to auditory stimuli: recovery process Electroencephalography and Clinical Neurophysiology 1966 21 2 105 113
31. Angel R. W., Quick W. M., Boylls C. C., Weinrich M., Rodnitzky R. L., Decrement of somatosensory evoked potentials during repetitive stimulation Electroencephalography and Clinical Neurophysiology 1985 60 4 335 342
32. Berardelli A., Rona S., Inghilleri M., Manfredi M., Cortical inhibition in Parkinson's disease: a study with paired magnetic stimulation Brain 1996 119 1 71 77
33. Kleine B. U., Praamstra P., Stegeman D. F., Zwarts M. J., Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulation Experimental Brain Research 2001 138 4 477 483
34. Krnjevi K., Randi M., Straughan D. W., Nature of a cortical inhibitory process Journal of Physiology 1966 184 1 49 77
35. Hanajima R., Ugawa Y., Intracortical inhibition of the motor cortex in movement disorders Brain and Development 2000 22 1 S32 S135
36. Olpe H.-R., Steinmann M. W., Greiner K., Pozza M. F., Contribution of presynaptic GABA-B receptors to paired-pulse depression of GABA-responses in the hippocampus Naunyn-Schmiedeberg's Archives of Pharmacology 1994 349 5 473 477
37. Deisz R. A., GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro Neuropharmacology 1999 38 11 1755 1766
38. Bergson C., Mrzljak L., Smiley J. F., Pappy M., Levenson R., Goldman-Rakic P. S., Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain Journal of Neuroscience 1995 15 12 7821 7836
39. Gonzalez-Islas C., Hablitz J. J., Dopamine inhibition of evoked IPSCs in rat prefrontal cortex Journal of Neurophysiology 2001 86 6 2911 2918
40. Surmeier D. J., Bargas J., Hemmings H. C. Jr., Nairn A. C., Greengard P., Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons Neuron 1995 14 2 385 397
41. Cantrell A. R., Tibbs V. C., Westenbroek R. E., Scheuer T., Catterall W. A., Dopaminergic modulation of voltage-gated Na+ current in rat hippocampal neurons requires anchoring of cAMP-dependent protein kinase The Journal of Neuroscience 1999 19, RC21 1 6
42. Zhou F.-M., Hablitz J. J., Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex Journal of Neurophysiology 1999 81 3 967 976
43. Shammah-Lagnado S. J., Alheid G. F., Heimer L., Efferent connections of the caudal part of the globus pallidus in the rat Journal of Comparative Neurology 1996 376 3 489 507
44. Boecker H., Ceballos-Baumann A., Bartenstein P., Weindl A., Siebner H. R., Fassbender T., Munz F., Schwaiger M., Conrad B., Sensory processing in Parkinson's and Huntington's disease. Investigations with 3D H215O-PET Brain 1999 122 9 1651 1665
45. Schneider J. S., Interactions between the basal ganglia, the pontine parabrachial region, and the trigeminal system in cat Neuroscience 1986 19 2 411 425
46. Kanda F., Jinnai K., Takahashi K., Abe H., Yasuda M., Tada K., Fujita T., Somatosensory evoked potentials in Huntington's diseasestudies with paired stimulation Electromyography and Clinical Neurophysiology 1989 29 5 287 291
47. Ugawa Y., Genba K., Shimpo T., Mannen T., Somatosensory evoked potential recovery (SEP-R) in myoclonic patients Electroencephalography and Clinical Neurophysiology 1991 80 1 21 25
48. Nagamoto H. T., Adler L. E., Waldo M. C., Griffith J., Freedman R., Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave Schizophrenia Research 1991 4 1 31 40
49. Schafer E. W. P., Peeke H. V. S., Down syndrome individuals fail to habituate cortical evoked potentials American Journal of Mental Deficiency 1982 87 3 332 337
50. Cullum C. M., Harris J. G., Waldo M. C., Smernoff E., Madison A., Nagamoto H. T., Griffith J., Adler L. E., Freedman R., Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia Schizophrenia Research 1993 10 2 131 141
51. Dawson M.E., Schell A. M., Swerdlow N. R., Filion D. L., Lang P. J., Simons R. F., Balaban M. T., Cognitive, clinical and neurophysiological implications of startle modification Attention and Orienting: Sensory and Motivational Processes 1997 Hillsdale, NJ, USA Lawrence Erlbaum 257 279
52. Elden., Flaten M. A., The relationship of automatic and controlled processing to prepulse inhibition Journal of Psychophysiology 2002 16 1 46 55
53. Levy G., Tang M.-X., Cote L. J., Louis E. D., Alfaro B., Mejia H., Stern Y., Marder K., Motor impairment in PD: relationship to incident dementia and age Neurology 2000 55 4 539 544
54. Peinemann A., Lehner C., Conrad B., Siebner H. R., Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex Neuroscience Letters 2001 313 1-2 33 36
55. Oliviero A., Profice P., Tonali P. A., Pilato F., Saturno E., Dileone M., Ranieri F., Di Lazzaro V., Effects of aging on motor cortex excitability Neuroscience Research 2006 55 1 74 77
56. Bertoli S., Probst R., Lack of standard N2 in elderly participants indicates inhibitory processing deficit Neuroreport 2005 16 17 1933 1937
57. Hua T., Kao C., Sun Q., Li X., Zhou Y., Decreased proportion of GABA neurons accompanies age-related degradation of neuronal function in cat striate cortex Brain Research Bulletin 2008 75 1 119 125
58. Schmidt S., Redecker C., Bruehl C., Witte O. W., Age-related decline of functional inhibition in rat cortex Neurobiology of Aging 2010 31 504 511
59. Gazzaley A., Clapp W., Kelley J., McEvoy K., Knight R. T., D'Esposito M., Age-related top-down suppression deficit in the early stages of cortical visual memory processing Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13122 13126
60. Fujiyama H., Garry M. I., Levin O., Swinnen S. P., Summers J. J., Age-related differences in inhibitory processes during interlimb coordination Brain Research 2009 1262 C 38 47
61. Katzen H. L., Levin B. E., Llabre M. L., Age of disease onset influences cognition in Parkinson's disease Journal of the International Neuropsychological Society 1998 4 3 285 290
62. Locascio J. J., Corkin S., Growdon J. H., Relation between clinical characteristics of Parkinson's disease and cognitive decline Journal of Clinical and Experimental Neuropsychology 2003 25 1 94 109
63. Muslimovi D., Post B., Speelman J. D., Schmand B., Cognitive profile of patients with newly diagnosed Parkinson disease Neurology 2005 65 8 1239 1245
64. Cooper J. A., Sagar H. J., Doherty S. M., Jordan N., Tidswell P., Sullivan E. V., Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease Brain 1992 115, part 6 1701 1725
65. Marshall F. H., Is the GABAB heterodimer a good drug target? Journal of Molecular Neuroscience 2005 26 2-3 169 175
66. Marshall F. H., Foord S. M., Heterodimerization of the GABAB receptor-implications for GPCR signaling and drug discovery Advances in Pharmacology 2010 57 C 63 91
67. Karaban N., Lukhanina E. P., Melnik N. A., Berezetskaya N. M., Influence of course treatment with Noofen on motor activity, cognitive functions and emotional state in patients with Parkinson's disease Ukrainskiy Vestnik Psihonevrologii 2006 14 46 26 30